Bio-Me AS
PrivateLast Round
Grant
Jun 28, 2021
Total Funding Raised
$2.6M
Company Overview
Bio-Me AS is a biotechnology company that provides Precision Microbiome Profiling (PMP™) services and develops microbiome-based molecular diagnostics with a focus on women's health.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Bio-Me AS Comparables
Compare Bio-Me AS with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Genetic Analysis AS | 82% | |
| SeqBiome Ltd | 78% | |
| Cmbio | 77% | |
Bio-Me AS Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 28, 2021 | ||||
| VC Round | Jun 10, 2021 | ||||
| Grant | Apr 23, 2020 | ||||
| Pre Seed | Nov 20, 2018 | ||||
| Accelerator | Aug 28, 2018 |
Key People
Founding team and executive leadership
Bio-Me AS Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Katapult Ocean | Accelerator |
| The Research Council of Norway | Grant |
Bio-Me AS Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Bio-Me AS's valuation, stock price, and market status.